Jones William Benton 4
4 · Corvus Pharmaceuticals, Inc. · Filed Dec 15, 2017
Insider Transaction Report
Form 4
Jones William Benton
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2017-12-13+40,000→ 40,000 totalExercise: $10.60Exp: 2027-12-13→ Common Stock (40,000 underlying)
Holdings
- 113,773
Common Stock, $0.0001 par value
Footnotes (2)
- [F1]A portion of these shares is subject to a right of repurchase held by the Issuer.
- [F2]The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 13, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.